Kiniksa Pharmaceuticals International (KNSA) EBITDA (2017 - 2026)
Kiniksa Pharmaceuticals International (KNSA) EBITDA from Jun 30, 2017 to Mar 31, 2026. The TTM Kiniksa Pharmaceuticals International (KNSA) EBITDA is $95M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Kiniksa Pharmaceuticals International (KNSA) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | +57.61% |
Annual EBITDA change of Kiniksa Pharmaceuticals International (KNSA)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $30M | -62.25% |
| 2025 | $79M | -279.37% |
| 2024 | -$44M | +92.21% |
| 2023 | -$23M | -287.60% |
| 2022 | $12M | -107.89% |
| 2021 | -$154M | -0.44% |
| 2020 | -$155M | -7.70% |
| 2019 | -$168M | +55.64% |
| 2018 | -$108M | +65.01% |
| 2017 | -$65M | N/A |